Clinical Trial Update: A Phase I Trial of Myeloablative Conditioning w/ Clofarabine and HD Busulfan for Pts w/ Refractory Heme Malignancies Undergoing Allo PBSCT [Phase 1]

View source ↗

Summary

A Phase I study evaluating conditioning with clofarabine and high-dose busulfan before allogeneic peripheral blood stem cell transplantation in patients with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Drugs mentioned

• BUSULFAN (Busulfan)
• Clofarabine (Clolar) (clofarabine)

Snippet

Sponsor: Indiana University School of Medicine | Conditions: Hematologic Malignancies | Phase 1 | Status: COMPLETED